We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Kyndryl
KD
$2.89B
| $2.36M | ﹤0.01% |
+88,766
| New | +$2.41M |
|
|
NB
1727
NioCorp Developments
NB
$759M
| $2.35M | ﹤0.01% |
443,898
-65,495
| -13% | -$451K |
|
1728
Allstate
ALL
$65.8B
| $2.34M | ﹤0.01% |
11,221
+3,514
| +46% | +$719K |
|
1729
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $2.33M | ﹤0.01% |
30,000
| – | – |
|
1730
PUT
Deere & Co
DE
$165B
| $2.33M | ﹤0.01% |
5,000
+1,200
| +32% | +$563K |
|
1731
Federal Agricultural Mortgage
AGM
$2.51B
| $2.31M | ﹤0.01% |
+13,130
| New | +$2.21M |
|
1732
CALL
Capital One
COF
$140B
| $2.3M | ﹤0.01% |
9,500
+7,600
| +400% | +$1.69M |
|
1733
Conagra Brands
CAG
$7.46B
| $2.3M | ﹤0.01% |
+132,932
| New | +$2.36M |
|
|
VOYG
1734
CALL
Voyager Technologies
VOYG
$2.59B
| $2.29M | ﹤0.01% |
+87,700
| New | +$2.38M |
|
|
BMNR
1735
BitMine Immersion Technologies
BMNR
$10.7B
| $2.29M | ﹤0.01% |
+84,407
| New | +$3.42M |
|
1736
PUT
Apollo Global Management
APO
$84B
| $2.29M | ﹤0.01% |
15,800
-6,400
| -29% | -$850K |
|
|
OKLO
1737
PUT
Oklo
OKLO
$8.5B
| $2.28M | ﹤0.01% |
31,800
-50,000
| -61% | -$5.58M |
|
|
JHG
1738
CALL
DELISTED
Janus Henderson
JHG
| $2.28M | ﹤0.01% |
+47,900
| New | +$2.12M |
|
1739
CALL
State Street Communication Services Select Sector SPDR ETF
XLC
$22.9B
| $2.27M | ﹤0.01% |
19,300
+5,800
| +43% | +$668K |
|
1740
Fortinet
FTNT
$119B
| $2.27M | ﹤0.01% |
28,571
+11,102
| +64% | +$921K |
|
1741
National Vision
EYE
$1.5B
| $2.27M | ﹤0.01% |
87,867
-129,213
| -60% | -$3.48M |
|
1742
Stevanato
STVN
$5.76B
| $2.26M | ﹤0.01% |
112,253
+98,013
| +688% | +$2.28M |
|
1743
CALL
Moderna
MRNA
$25.2B
| $2.25M | ﹤0.01% |
76,400
+59,700
| +357% | +$1.62M |
|
|
CALY
1744
Callaway Golf Company
CALY
$2.95B
| $2.25M | ﹤0.01% |
192,839
-2,303,436
| -92% | -$24.3M |
|
1745
Nurix Therapeutics
NRIX
$2.78B
| $2.25M | ﹤0.01% |
118,481
-3,102
| -3% | -$44.6K |
|
1746
CALL
UiPath
PATH
$8.36B
| $2.24M | ﹤0.01% |
136,600
-148,400
| -52% | -$2.31M |
|
1747
HCA Healthcare
HCA
$87.9B
| $2.24M | ﹤0.01% |
4,788
-2,382
| -33% | -$1.11M |
|
1748
Altria Group
MO
$110B
| $2.23M | ﹤0.01% |
38,636
-1,694,039
| -98% | -$102M |
|
1749
ASML
ASML
$702B
| $2.22M | ﹤0.01% |
2,076
-135,252
| -98% | -$141M |
|
1750
Takeda Pharmaceutical
TAK
$56.2B
| $2.2M | ﹤0.01% |
+141,024
| New | +$2.02M |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.